8,11 Providers should take care to introduce pharmacotherapy in a manner that does not imply failure of will nor detract from the self-efficacy and autonomous motivation that many patients bring to their obesity management
M.FinkelT
Despite the significant potential and advantages of GLP-1RAs, they are inevitably accompanied by a range of possible adverse drug reactions (ADRs), as is the case with any medication
[DOI] [PMC free article] [PubMed] [Google Scholar] 195.Gojkovic S., Krezic I., Vrdoljak B., Malekinusic D., Barisic I., Petrovic A., Horvat Pavlov K., Kolovrat M., Duzel A., Knezevic M., et al
Glutathione is available both as an oral supplement and via IV
Where there is reduced access to GLP-1 RAs, support people with type 2 diabetes to access to structured education and weight management programmes where available